FDA Inspection 822454 — Central Jersey Blood Center, Inc.
The FDA completed an inspection of Central Jersey Blood Center, Inc. on Mar 12, 2013 in Shrewsbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 12, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shrewsbury, NJ (United States)